glyburide has been researched along with Pre-Eclampsia in 7 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin has been reported to reduce the risk of pre-eclampsia." | 8.98 | Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials. ( Abdi, A; Kalafat, E; Khalil, A; Sukur, YE; Thilaganathan, B, 2018) |
| "Metformin has been reported to reduce the risk of pre-eclampsia." | 4.98 | Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials. ( Abdi, A; Kalafat, E; Khalil, A; Sukur, YE; Thilaganathan, B, 2018) |
| "The 5 mg/day glyburide dose did not increase maternal hypoglycemia (26% in the 2." | 3.83 | Examining the Starting Dose of Glyburide in Gestational Diabetes. ( Biggio, JR; Glover, AV; Harper, LM; Tita, A, 2016) |
| "In a large managed care organization, glyburide was at least as effective as insulin in achieving glycemic control and similar birth weights in women with GDM who failed diet therapy." | 3.73 | Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. ( Ching, JY; Ferrara, A; Field, DR; Jacobson, GF; Kirby, RS; Ramos, GA, 2005) |
| "Glyburide was more likely to fail in women diagnosed earlier in pregnancy, of older age and multiparity, and with higher fasting glucoses, suggesting that earlier glucose intolerance and a reduced capacity to respond to an insulin secretagogue may distinguish this group." | 3.73 | Predictors of glyburide failure in the treatment of gestational diabetes. ( Barbour, LA; Davies, JK; Kahn, BF; Lynch, AM; Reynolds, RM, 2006) |
| "Maternal characteristics and outcomes (preeclampsia and weight gain) and neonatal outcomes (birth weight and percentile, hypoglycemia, jaundice, and respiratory morbidity) were compared between groups." | 1.91 | Insulin Detemir Versus Glibenclamide in Gestational Diabetes Mellitus: A Retrospective Cohort Study. ( Fakterman, M; Kovo, M; Leytes, S; Ravid, D; Weitzner, O; Yagur, Y, 2023) |
| "Successful rat models for preeclampsia were confirmed based on mean arterial pressure, a 24-h protein urine test, and by observing the structure of the kidney by transmission electron microscopy (TEM)." | 1.48 | Role of AKR1C3 in renal injury and glibenclamide is anti-inflammatory in preeclamptic rats. ( Jin, Y; Li, L; Liu, XW; Sun, CJ; Zhang, WY, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ravid, D | 1 |
| Kovo, M | 1 |
| Leytes, S | 1 |
| Yagur, Y | 1 |
| Fakterman, M | 1 |
| Weitzner, O | 1 |
| Sun, CJ | 1 |
| Jin, Y | 1 |
| Zhang, WY | 1 |
| Li, L | 1 |
| Liu, XW | 1 |
| Kalafat, E | 1 |
| Sukur, YE | 1 |
| Abdi, A | 1 |
| Thilaganathan, B | 1 |
| Khalil, A | 1 |
| Glover, AV | 1 |
| Tita, A | 1 |
| Biggio, JR | 1 |
| Harper, LM | 1 |
| Jacobson, GF | 1 |
| Ramos, GA | 1 |
| Ching, JY | 1 |
| Kirby, RS | 1 |
| Ferrara, A | 1 |
| Field, DR | 1 |
| Rand, L | 1 |
| Caughey, AB | 1 |
| Kahn, BF | 1 |
| Davies, JK | 1 |
| Lynch, AM | 1 |
| Reynolds, RM | 1 |
| Barbour, LA | 1 |
1 review available for glyburide and Pre-Eclampsia
| Article | Year |
|---|---|
Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials.
Topics: Bayes Theorem; Diabetes, Gestational; Female; Glyburide; Humans; Hypertension, Pregnancy-Induced; In | 2018 |
6 other studies available for glyburide and Pre-Eclampsia
| Article | Year |
|---|---|
Insulin Detemir Versus Glibenclamide in Gestational Diabetes Mellitus: A Retrospective Cohort Study.
Topics: Birth Weight; Diabetes, Gestational; Female; Glucose; Glyburide; Humans; Infant; Infant, Newborn; In | 2023 |
Role of AKR1C3 in renal injury and glibenclamide is anti-inflammatory in preeclamptic rats.
Topics: Acute Kidney Injury; Aldo-Keto Reductase Family 1 Member C3; Animals; Anti-Inflammatory Agents; Dise | 2018 |
Examining the Starting Dose of Glyburide in Gestational Diabetes.
Topics: Adult; Birth Weight; Cesarean Section; Cohort Studies; Diabetes, Gestational; Dystocia; Female; Feta | 2016 |
Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
Topics: Adult; Birth Weight; Blood Glucose; Diabetes, Gestational; Fasting; Female; Glucose Tolerance Test; | 2005 |
Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
Topics: Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; Managed Care Program | 2006 |
Predictors of glyburide failure in the treatment of gestational diabetes.
Topics: Adult; Cesarean Section; Diabetes, Gestational; Female; Fetal Macrosomia; Glyburide; Humans; Hypogly | 2006 |